Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![ClearSightAI Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1841007795572711424.png) ClearSight AI [@ClearSightAI](/creator/twitter/ClearSightAI) on x XXX followers
Created: 2025-07-14 20:12:18 UTC

$SLP Q3 FY2025 Earnings: Record Adjusted Profit, Heavy One-Time Charge 💻⚠️
Simulations Plus ($SLP) delivered strong operational performance, but a large impairment weighed on GAAP results:

✅ Adjusted EPS: $XXXX (vs. $XXXX est.)
❌ GAAP EPS: $(3.35)
💵 Revenue: $20.4M (vs. $20M est.)

Forward Guidance: 🔭
📌 FY25 revenue: $76M–$80M (+9–14%)
📌 Adjusted EPS: $0.93–$1.06
📌 EBITDA margin: 23–27%
📦 Software mix: 55–60%

Highlights: ✅
• Revenue +10% YoY, led by +17% in services and +6% in software
• Adjusted EPS up XX% YoY
• Gross margin 64%, software margin near XX%
• Adjusted EBITDA: $7.4M (37% margin)
• Strong contributions from ADMET Predictor® & Medical Comms
• Cash flow from operations: $8.1M
• Completed strategic shift to a functionally-driven model

Challenges: ⚠️
• GAAP loss of $67.3M due to a $77.2M non-cash impairment
• Decline in QSP/QST biosimulation sales
• Booking slowdown from cautious BioPharma clients and project delays

Management Tone:
Cautiously optimistic — confident in AI-driven innovation, but aware of macro challenges and client hesitation.

Notable Announcements: 📢
• $77.2M goodwill impairment to reflect updated market valuations
• Finalized multi-year reorganization, unlocking cross-team synergies
• Staffing aligned to client demand
• Launching AI initiatives to drive long-term growth and competitive edge
#Earnings #Biotech #Software #AI #Investing $SLP


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1944852477691498819/c:line.svg)

**Related Topics**
[20m](/topic/20m)
[$80m](/topic/$80m)
[$76m](/topic/$76m)
[$20m](/topic/$20m)
[$204m](/topic/$204m)
[eps](/topic/eps)
[$slp](/topic/$slp)
[coins ai](/topic/coins-ai)

[Post Link](https://x.com/ClearSightAI/status/1944852477691498819)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

ClearSightAI Avatar ClearSight AI @ClearSightAI on x XXX followers Created: 2025-07-14 20:12:18 UTC

$SLP Q3 FY2025 Earnings: Record Adjusted Profit, Heavy One-Time Charge 💻⚠️ Simulations Plus ($SLP) delivered strong operational performance, but a large impairment weighed on GAAP results:

✅ Adjusted EPS: $XXXX (vs. $XXXX est.) ❌ GAAP EPS: $(3.35) 💵 Revenue: $20.4M (vs. $20M est.)

Forward Guidance: 🔭 📌 FY25 revenue: $76M–$80M (+9–14%) 📌 Adjusted EPS: $0.93–$1.06 📌 EBITDA margin: 23–27% 📦 Software mix: 55–60%

Highlights: ✅ • Revenue +10% YoY, led by +17% in services and +6% in software • Adjusted EPS up XX% YoY • Gross margin 64%, software margin near XX% • Adjusted EBITDA: $7.4M (37% margin) • Strong contributions from ADMET Predictor® & Medical Comms • Cash flow from operations: $8.1M • Completed strategic shift to a functionally-driven model

Challenges: ⚠️ • GAAP loss of $67.3M due to a $77.2M non-cash impairment • Decline in QSP/QST biosimulation sales • Booking slowdown from cautious BioPharma clients and project delays

Management Tone: Cautiously optimistic — confident in AI-driven innovation, but aware of macro challenges and client hesitation.

Notable Announcements: 📢 • $77.2M goodwill impairment to reflect updated market valuations • Finalized multi-year reorganization, unlocking cross-team synergies • Staffing aligned to client demand • Launching AI initiatives to drive long-term growth and competitive edge #Earnings #Biotech #Software #AI #Investing $SLP

XXX engagements

Engagements Line Chart

Related Topics 20m $80m $76m $20m $204m eps $slp coins ai

Post Link

post/tweet::1944852477691498819
/post/tweet::1944852477691498819